Data / Form D filings / Consano Bio, Inc.
Consano Bio, Inc.: Form D filings
Consano Bio, Inc., a biotechnology company in Burlington, MA, filed 3 Form D notices with the SEC between 2023 and 2026. The latest, on March 20, 2026, reports $34.8 million sold of a $48.9 million offering to 28 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 SUMMIT DRIVE, Burlington, MA, 01803
- Phone
- (617) 798-4559
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1981285
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | New notice | $48,858,795 | $34,824,466 | $14,034,329 | 28 | Mar 6, 2026 | sec.gov |
| Dec 12, 2025 | New notice | $16,840,000 | $16,840,000 | 18 | Oct 15, 2024 | sec.gov | |
| Jun 13, 2023 | New notice | $12,000,000 | $7,900,000 | $4,100,000 | 1 | Jun 13, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Hall | Executive Officer, Director | Chief Executive Officer and Secretary of Issuer |
| Jennifer Schmitke | Executive Officer | President and Chief Operating Officer of Issuer |
| Doug Vander Weide | Director | |
| Christopher Centeno | Director | |
| Bill Abbington | Director | |
| Jerome Adams | Director | |
| Michael Pede | Director | |
| Joe Schiesl | Director | |
| John Conway | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Consano Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.